Literature DB >> 19665620

Surgery in the patient with liver disease.

Diego J Muilenburg1, Amrik Singh, Guido Torzilli, Vijay P Khatri.   

Abstract

Liver dysfunction is a prominent entity in Western medicine that has historically affected patients suffering from chronic viral or alcoholic hepatitis. The incidence of these conditions has not changed dramatically in recent years but the overall number of patients with liver dysfunction has increased considerably with the emergence of the obesity epidemic. Nonalcoholic fatty liver disease (NAFLD) has become increasingly recognized as the most common cause of chronic liver disease in the United States. Although the rate of progression of NAFLD to overt cirrhosis is low, the high prevalence of this condition, combined with the moderate degree of liver dysfunction it engenders, has resulted in a significant increase in the number of patients with liver disease that can be encountered by a surgical practice. Any degree of clinically evident liver disease in a prospective surgical patient should raise concern for the entire surgical team. This particularly applies to intraabdominal surgery whereby the presence of hepatomegaly, portal hypertension, variceal bleeding, and ascites can turn even the most routine operation into a morbid and life-threatening procedure. Nonabdominal surgery avoids some of the technical challenges presented by liver disease but the anesthetic management of a cirrhotic patient still makes any operation potentially more dangerous. In this article, approaches to minimize the risk when surgery becomes necessary in the presence of liver disease are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19665620     DOI: 10.1016/j.mcna.2009.05.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

1.  The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study.

Authors:  Chung-Feng Huang; Jee-Fu Huang; Wu-Cheng Chen; Ming-Lun Yeh; Ching-I Huang; Jeng-Fu Yang; Wan-Long Chuang; Chia-Yen Dai; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Lung Yu
Journal:  Hepatol Int       Date:  2012-08-11       Impact factor: 6.047

Review 2.  Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions.

Authors:  Kira L Newman; Kay M Johnson; Paul B Cornia; Peter Wu; Kamal Itani; George N Ioannou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-31       Impact factor: 11.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.